Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 45 Colorectal Neoplasms 45 Esophageal Neoplasms 28 Esophageal Squamous Cell Carcinoma 24 Stomach Neoplasms 22 Pancreatic Neoplasms 19 Colonic Neoplasms 18 Adenocarcinoma Of Esophagus 15 Carcinoma, Hepatocellular 14 Neoplasm Metastasis 7 Liver Neoplasms 6 Cholangiocarcinoma 5 Recurrence 4 Locally Advanced Rectal Cancer 4 Turcot syndrome 3 Peritoneal Neoplasms 2 Neoplasms 2 Gastrointestinal Stromal Tumors 2 Breast Neoplasms 2 Bites and Stings 2 Adenocarcinoma 2 Surgery 1 Successful Conversion Rate of Operation 1 Radiation Injuries 1 QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1 Peritoneal Metastases From Gastric Cancer 1 Peritoneal Metastases From Colorectal Cancer 1 Pathologic Complete Response 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Ductal Adenocarcinoma 1

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophagogastric Cancer × Neoadjuvant Therapy × Gastrointestinal × Clear all

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡